Company overview
Elsevier provides advanced information solutions, scientific databases, and analytics platforms tailored for pharmaceutical R&D and procurement leaders. Their offerings include comprehensive drug intelligence, clinical trial data, and decision support tools to accelerate research and streamline vendor evaluation. These resources support life sciences professionals in sourcing, risk assessment, and regulatory compliance worldwide.
Elsevier is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include elsevier pharma, pharma data analytics, drug intelligence, r&d databases, supplier evaluation tools.
Structured facts
- Website
- https://www.elsevier.com
- Markets served
- United States & Americas
- Keywords
- elsevier pharma, pharma data analytics, drug intelligence, r&d databases, supplier evaluation tools
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What data solutions does Elsevier offer for pharma R&D?
- Elsevier delivers scientific databases, drug intelligence platforms, and analytics tools including clinical trial data and patent information to support drug discovery and development pipelines.
- How does Elsevier assist with pharmaceutical procurement and supplier evaluation?
- Elsevier's platforms provide supplier discovery intelligence, risk analytics, and category spend insights to help procurement leaders identify, qualify, and manage vendors effectively.
- What are Elsevier's global capabilities and regulatory support for pharma?
- As a global provider, Elsevier offers decision support compliant with international standards, covering geographies like North America, Europe, and Asia Pacific for pharma supply chain needs.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
